Clinical Trials Browser

Withdrawn × OTHER × Toremifene × Clear all

NCT03238703 2018-12-27

Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer

Phase 4 Withdrawn

Breast Carcinoma In Situ, Breast Neoplasms

NCT00003865 2017-07-13

Toremifene in Treating Patients With Ovarian Cancer

Phase 2 Withdrawn

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms